Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Dude51on Apr 07, 2021 12:15pm

100 Views

Post# 32949650

7 TD Sec, keeping busy i see, shorter?

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
11:57:53	V	0.04	-0.005	10,000	7 TD Sec	7 TD Sec	K
11:53:15	M	0.045		750	88 Credential	2 RBC
11:53:15	M	0.0425	-0.0025	1,000	88 Credential	1 Anonymous
11:49:01	V	0.04	-0.005	250	68 Leede	7 TD Sec
11:49:01	V	0.04	-0.005	1,000	7 TD Sec	7 TD Sec	K
11:44:45	U	0.045		20,000	2 RBC	1 Anonymous	K
11:44:45	U	0.045		50,000	2 RBC	2 RBC	K
11:21:44	A	0.04	-0.005	40,000	1 Anonymous	85 Scotia	K
11:05:19	A	0.04	-0.005	10,000	1 Anonymous	124 Questrade	K
10:57:59	V	0.04	-0.005	3,000	7 TD Sec	7 TD Sec	K